Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novo Nordisk characterizes potential antipsychotic agent

March 11, 1997

Preclinical toxicity, pharmacokinetics and metabolism of SM-9018 described

March 10, 1997

Agents for CNS disorders described by American Home Products

March 10, 1997

Vyrex and Immune Response form collaboration

March 7, 1997

AIT-082 enters clinic

March 7, 1997

Teva receives tentative approval for ketorolac tromethamine

March 7, 1997

Cypros receives SBIR grant

March 6, 1997

Neuroimmunophilin ligand shows promise for Parkinson's disease

March 6, 1997

Glaxo Wellcome evaluates melatonin agonist

March 6, 1997

Abbott describes AK inhibitor with anticonvulsant/neuroprotective effects

March 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...